Comments
Aurobindo Pharma Ltd’s consolidated net profit increased manifold at Rs 501 crore in the fourth quarter ended March 31, 2014 compared to Rs 108 crore in the year-ago period driven by growth in formulations sale.
The total revenue of the Hyderabad-based company grew by 48.4 per cent at Rs 2,329 crore (Rs 1,570 cr).
For the full-year, profit increased to Rs 1,173 crore (Rs 294 cr). Total revenue grew to Rs 8,100 crore (Rs 5,855 crore).
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.